Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer
Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investig...
Saved in:
Published in | Phytomedicine (Stuttgart) Vol. 57; pp. 117 - 128 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Elsevier GmbH
01.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown.
To investigate the effect of TPT on metabolism in gastric cancer.
ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting.
TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT.
TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT.
[Display omitted] |
---|---|
AbstractList | BACKGROUNDTopotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown.PURPOSETo investigate the effect of TPT on metabolism in gastric cancer.METHODSATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting.RESULTSTPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT.CONCLUSIONTPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT. Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investigate the effect of TPT on metabolism in gastric cancer. ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting. TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT. TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT. Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase nutrients uptake, which has already been a hallmark of cancer. But the effect of TPT on metabolism in gastric cancer remains unknown. To investigate the effect of TPT on metabolism in gastric cancer. ATP production was measured by ATP Assay kit. Glucose and glutamine uptake were measured by Glucose (HK) Assay Kit and Glutamine/Glutamate Determination Kit respectively. To detect glutathione (GSH) concentration and reactive oxygen species (ROS) generation, GSH and GSSG Assay Kit and ROS Assay Kit were adopted. Apoptosis rates, mitochondrial membrane potential (MMP) were determined by flow cytometry and protein levels were analyzed by immumohistochemical staining and western blotting. TPT increased ATP production. TPT promoted glucose uptake possibly via up-regulation of hexokinase 2 (HK2) or glucose transporter 1 (GLUT1) expression, while decreased glutamine uptake by down-regulation of ASCT2 expression. ASCT2 inhibitor GPNA and ASCT2 knockdown significantly suppressed the growth of gastric cancer cells. Inhibition of ASCT2 reduced glutamine uptake which led to decreased production of GSH and increased ROS level. ASCT2 knockdown induced apoptosis via the mitochondrial pathway and weakened anti-cancer effect of TPT. TPT inhibits glutamine uptake via down-regulation of ASCT2 which causes oxidative stress and induces apoptosis through the mitochondrial pathway. Moreover, TPT inhibits proliferation partially via ASCT2. These observations reveal a previously undescribed mechanism of ASCT2 regulated gastric cancer proliferation and demonstrate ASCT2 is a potential anti-cancer target of TPT. [Display omitted] |
Author | Li, Zheng-Zheng He, Jin-Yong Du, Hong-Zhi Yuan, Sheng-Tao Sun, Li Zhao, Ting-Li Zhang, Ben-Jia Liu, Yang Wang, Lai Jiang, Jing-Wei |
Author_xml | – sequence: 1 givenname: Lai surname: Wang fullname: Wang, Lai organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 2 givenname: Yang surname: Liu fullname: Liu, Yang organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 3 givenname: Ting-Li surname: Zhao fullname: Zhao, Ting-Li organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 4 givenname: Zheng-Zheng surname: Li fullname: Li, Zheng-Zheng organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 5 givenname: Jin-Yong surname: He fullname: He, Jin-Yong organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 6 givenname: Ben-Jia surname: Zhang fullname: Zhang, Ben-Jia organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 7 givenname: Hong-Zhi surname: Du fullname: Du, Hong-Zhi organization: School of Pharmacy, Hubei University of Chinese Medicine, Huang jia hu Road West, Wuhan, China – sequence: 8 givenname: Jing-Wei surname: Jiang fullname: Jiang, Jing-Wei organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 9 givenname: Sheng-Tao surname: Yuan fullname: Yuan, Sheng-Tao email: yuanst@cpu.edu.cn organization: Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China – sequence: 10 givenname: Li surname: Sun fullname: Sun, Li email: sunli@cpu.edu.cn organization: Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30668314$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtLAzEQx4NUbH18A5EcveyaSdLt5iKU4gsEESt4CzGZ1ZR2sybbot_elNarpxmY_4P5HZNBG1ok5BxYCQyqq0XZff6s0JWcQV0CLxnAARlBBXXB1PhtQEZMSVlMAMSQHKe0YAykmrAjMhSsqmoBckSe56ELPVrTUt-6tcVETRe6PiSf6MYbOn2ZzTnNPd706Gj49s70foM09RFTyi76YfLuLc0hFuMpOWzMMuHZfp6Q19ub-ey-eHy6e5hNHwsrKt4XzqJFFGNXG8UbNa5cIyonnWUN52OpuEXTGCYMYxLYpFI1SO6UNaJuQCgjTsjlLreL4WuNqdcrnywul6bFsE6aw0RJLkStslTupDaGlCI2uot-ZeKPBqa3MPVC72DqLUwNXGeY2Xaxb1i_b29_pj96WXC9E2D-c-Mx6mQ9ZgjOR7S9dsH_3_ALjSeJuw |
CitedBy_id | crossref_primary_10_1007_s10863_024_10008_z crossref_primary_10_1007_s10616_023_00588_w crossref_primary_10_1007_s12094_023_03278_3 crossref_primary_10_1080_01635581_2022_2076889 crossref_primary_10_1158_1535_7163_MCT_20_0354 crossref_primary_10_3389_fonc_2019_01202 crossref_primary_10_3389_fphar_2024_1345522 crossref_primary_10_3390_cancers15205082 crossref_primary_10_1016_j_apsb_2022_07_021 crossref_primary_10_2139_ssrn_4176716 crossref_primary_10_1007_s13659_020_00283_9 crossref_primary_10_1016_j_apsb_2021_09_019 crossref_primary_10_3389_fimmu_2023_1221530 crossref_primary_10_1007_s10495_022_01709_0 crossref_primary_10_1007_s10735_022_10070_0 crossref_primary_10_1371_journal_pone_0261370 crossref_primary_10_1093_jas_skaa138 crossref_primary_10_1016_j_gastrohep_2020_05_017 crossref_primary_10_1016_j_phymed_2024_155583 crossref_primary_10_1016_j_tifs_2021_10_007 crossref_primary_10_1007_s00280_020_04218_6 crossref_primary_10_1177_15347354211045349 crossref_primary_10_1016_j_bcp_2023_115464 crossref_primary_10_1007_s11064_019_02934_x crossref_primary_10_3390_cancers13020203 crossref_primary_10_1016_j_gastre_2020_05_011 |
Cites_doi | 10.1172/JCI69600 10.1074/jbc.273.23.14484 10.1016/j.celrep.2014.04.045 10.1016/S0962-8924(00)01803-1 10.1016/j.bpj.2012.12.010 10.1016/j.ejphar.2017.10.014 10.1016/j.bmc.2004.11.028 10.1016/j.cmet.2015.12.006 10.3892/or.2013.2272 10.1186/s40170-015-0128-2 10.1016/j.ceb.2004.09.009 10.1146/annurev-bioeng-071516-044546 10.1126/science.1218595 10.1128/MCB.22.16.5793-5800.2002 10.1038/ncb0311-184 10.1111/bph.13765 10.1016/j.molcel.2012.05.043 10.1038/nature12040 10.18632/oncotarget.8843 10.1038/nrc3557 10.1038/onc.2015.381 10.1038/nature13236 10.1038/s41598-017-07631-9 10.3389/fonc.2012.00060 10.1074/jbc.274.17.11647 10.1002/path.4518 10.1016/j.freeradbiomed.2016.04.198 10.18632/oncotarget.19479 10.1002/msb.20134892 10.1038/nrc2663 10.1007/s00109-011-0731-9 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4 10.1016/j.mam.2018.02.003 10.1054/bjoc.2000.1353 |
ContentType | Journal Article |
Copyright | 2018 Copyright © 2018. Published by Elsevier GmbH. |
Copyright_xml | – notice: 2018 – notice: Copyright © 2018. Published by Elsevier GmbH. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.phymed.2018.12.011 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1618-095X |
EndPage | 128 |
ExternalDocumentID | 10_1016_j_phymed_2018_12_011 30668314 S0944711318306068 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1~. 1~5 29O 3V. 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X2 7X7 88E 88I 8AF 8FE 8FH 8FI 8FJ 8P~ 8R4 8R5 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AAKPP AALRI AAOAW AAQFI AAQXK AATCM AAWTL AAXUO AAYOK ABBQC ABFNM ABFRF ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABUWG ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACGOD ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKRA AFKWA AFRAH AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AIXEN AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG ATCPS AVWKF AXJTR AZFZN AZQEC BENPR BES BHPHI BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CAG CCPQU COF CS3 DOVZS DU5 DWQXO EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ HCIFZ HMCUK HVGLF HX~ HZ~ IAG IAO IEA IHA IHE IHR INH INR IOF ISR J1W KOM LCYCR M0K M1P M2P M2Q M41 MO0 N9A NAPCQ O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. PCD PQQKQ PROAC PSQYO PV9 Q2X Q38 R2- RIG ROL RPZ RWL RXW RZL S0X SCC SDF SDG SEL SES SEW SPCBC SSH SSP SSU SSZ T5I T5K TAE UKHRP UNMZH WOW ~G- ~KM AAHBH AAXKI AKRWK ALIPV NPM AAYXX AFJKZ CITATION ITC 7X8 |
ID | FETCH-LOGICAL-c362t-dcecee35d8a92f956df36d4dc0f225492ceafa03a004107698142d9ca38f139a3 |
IEDL.DBID | AIKHN |
ISSN | 0944-7113 |
IngestDate | Fri Aug 16 01:44:41 EDT 2024 Thu Sep 26 15:51:12 EDT 2024 Sat Sep 28 08:41:37 EDT 2024 Fri Feb 23 02:49:36 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Oxidative stress GSSG Topotecan GPT GDH GOT GLS PSAT ASCT2 α-KG NEAAs ROS ME-1 TPT Gastric cancer GSH GPNA Apoptosis |
Language | English |
License | Copyright © 2018. Published by Elsevier GmbH. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c362t-dcecee35d8a92f956df36d4dc0f225492ceafa03a004107698142d9ca38f139a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 30668314 |
PQID | 2179423389 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2179423389 crossref_primary_10_1016_j_phymed_2018_12_011 pubmed_primary_30668314 elsevier_sciencedirect_doi_10_1016_j_phymed_2018_12_011 |
PublicationCentury | 2000 |
PublicationDate | 2019-04-01 |
PublicationDateYYYYMMDD | 2019-04-01 |
PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Phytomedicine (Stuttgart) |
PublicationTitleAlternate | Phytomedicine |
PublicationYear | 2019 |
Publisher | Elsevier GmbH |
Publisher_xml | – name: Elsevier GmbH |
References | Desagher, Martinou (bib0008) 2000; 10 Shanware, Mullen, DeBerardinis, Abraham (bib0027) 2011; 89 Ulrich-Merzenich, Zeitler, Vetter, Kraft (bib0030) 2009; 16 Phang, Liu, Hancock, Christian (bib0025) 2012; 2 Hensley, Wasti, DeBerardinis (bib0016) 2013; 123 Pavlova, Thompson (bib0024) 2016; 23 Jain, Nilsson, Sharma, Madhusudhan, Kitami, Souza, Kafri, Kirschner, Clish, Mootha (bib0017) 2012; 336 Hara, Yonezawa, Weng, Kozlowski, Belham, Avruch (bib0014) 1998; 273 Yang, Venneti, Nagrath (bib0034) 2017; 19 Du, Liu, Chen, Yu, Hou, Li, Zhan, Lin, Lu, Yuan, Sun (bib0010) 2018; 818 Ahn, Metallo (bib0001) 2015; 3 Nikiforov, Chandriani, O'Connell, Petrenko, Kotenko, Beavis, Sedivy, Cole (bib0023) 2002; 22 Son, Lyssiotis, Ying, Wang, Hua, Ligorio, Perera, Ferrone, Mullarky, Shyh-Chang, Kang, Fleming, Bardeesy, Asara, Haigis, DePinho, Cantley, Kimmelman (bib0028) 2013; 496 van Geldermalsen, Wang, Nagarajah, Marshall, Thoeng, Gao, Ritchie, Feng, Bailey, Deng, Harvey, Beith, Selinger, O'Toole, Rasko, Holst (bib0031) 2016; 35 Yu, Lin, Du, Zhao, Feng, Yu, Zhang, Li, Qian, Luo, Yuan, Sun (bib0035) 2016; 7 Zhao, Sun, Lin, Bai, Yu, Yuan, Zhang (bib0036) 2013; 29 Cotter (bib0006) 2009; 9 Fan, Ye, Kamphorst, Shlomi, Thompson, Rabinowitz (bib0013) 2014; 510 Chen, Dai, Zou, Chen, Rajamanickam, Feng, Zhuge, Qiu, Ye, Zhang, Liang (bib0005) 2017; 174 Tabas, Ron (bib0029) 2011; 13 Kimball, Shantz, Horetsky, Jefferson (bib0019) 1999; 274 Esslinger, Cybulski, Rhoderick (bib0012) 2005; 13 Scott, Lamb, Smith, Wheatley (bib0026) 2000; 83 Diebold, Chandel (bib0009) 2016; 100 Duran, Oppliger, Robitaille, Heiserich, Skendaj, Gottlieb, Hall (bib0011) 2012; 47 Lu, Chen, Tao, Gao, Li, Cao, Lu, Zou (bib0022) 2017; 8 Breckenridge, Xue (bib0004) 2004; 16 DeBerardinis, Mancuso, Daikhin, Nissim, Yudkoff, Wehrli, Thompson (bib0007) 2007; 104 Yang, Moss, Mangala, Marini, Zhao, Wahlig, Armaiz-Pena, Jiang, Achreja, Win, Roopaimoole, Rodriguez-Aguayo, Mercado-Uribe, Lopez-Berestein, Liu, Tsukamoto, Sood, Ram, Nagrath (bib0033) 2014; 10 Bernstock, Ye (bib0002) 2017; 7 Wang, Hardie, Hoy, van Geldermalsen, Gao, Fazli, Sadowski, Balaban, Schreuder, Nagarajah, Wong, Metierre, Pinello, Otte, Lehman, Gleave, Nelson, Bailey, Ritchie, Rasko, Holst (bib0032) 2015; 236 Helfinger, Schroder (bib0015) 2018; 63 Labuschagne, van den Broek, Mackay, Vousden, Maddocks (bib0020) 2014; 7 Locasale (bib0021) 2013; 13 Bleicken, Wagner, Garcia-Saez (bib0003) 2013; 104 Kaufmann, Gores (bib0018) 2015; 22 Hara (10.1016/j.phymed.2018.12.011_bib0014) 1998; 273 Shanware (10.1016/j.phymed.2018.12.011_bib0027) 2011; 89 Labuschagne (10.1016/j.phymed.2018.12.011_bib0020) 2014; 7 Helfinger (10.1016/j.phymed.2018.12.011_bib0015) 2018; 63 Chen (10.1016/j.phymed.2018.12.011_bib0005) 2017; 174 Breckenridge (10.1016/j.phymed.2018.12.011_bib0004) 2004; 16 Esslinger (10.1016/j.phymed.2018.12.011_bib0012) 2005; 13 Wang (10.1016/j.phymed.2018.12.011_bib0032) 2015; 236 Yang (10.1016/j.phymed.2018.12.011_bib0033) 2014; 10 Diebold (10.1016/j.phymed.2018.12.011_bib0009) 2016; 100 Nikiforov (10.1016/j.phymed.2018.12.011_bib0023) 2002; 22 Kimball (10.1016/j.phymed.2018.12.011_bib0019) 1999; 274 Zhao (10.1016/j.phymed.2018.12.011_bib0036) 2013; 29 Desagher (10.1016/j.phymed.2018.12.011_bib0008) 2000; 10 Cotter (10.1016/j.phymed.2018.12.011_bib0006) 2009; 9 Pavlova (10.1016/j.phymed.2018.12.011_bib0024) 2016; 23 Bernstock (10.1016/j.phymed.2018.12.011_bib0002) 2017; 7 Du (10.1016/j.phymed.2018.12.011_bib0010) 2018; 818 Duran (10.1016/j.phymed.2018.12.011_bib0011) 2012; 47 Ahn (10.1016/j.phymed.2018.12.011_bib0001) 2015; 3 Lu (10.1016/j.phymed.2018.12.011_bib0022) 2017; 8 Fan (10.1016/j.phymed.2018.12.011_bib0013) 2014; 510 Phang (10.1016/j.phymed.2018.12.011_bib0025) 2012; 2 DeBerardinis (10.1016/j.phymed.2018.12.011_bib0007) 2007; 104 Kaufmann (10.1016/j.phymed.2018.12.011_bib0018) 2015; 22 Locasale (10.1016/j.phymed.2018.12.011_bib0021) 2013; 13 Jain (10.1016/j.phymed.2018.12.011_bib0017) 2012; 336 Son (10.1016/j.phymed.2018.12.011_bib0028) 2013; 496 Ulrich-Merzenich (10.1016/j.phymed.2018.12.011_bib0030) 2009; 16 Yu (10.1016/j.phymed.2018.12.011_bib0035) 2016; 7 Tabas (10.1016/j.phymed.2018.12.011_bib0029) 2011; 13 Hensley (10.1016/j.phymed.2018.12.011_bib0016) 2013; 123 van Geldermalsen (10.1016/j.phymed.2018.12.011_bib0031) 2016; 35 Scott (10.1016/j.phymed.2018.12.011_bib0026) 2000; 83 Yang (10.1016/j.phymed.2018.12.011_bib0034) 2017; 19 Bleicken (10.1016/j.phymed.2018.12.011_bib0003) 2013; 104 |
References_xml | – volume: 7 start-page: 7425 year: 2017 ident: bib0002 article-title: Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming publication-title: Sci. Rep. contributor: fullname: Ye – volume: 9 start-page: 501 year: 2009 end-page: 507 ident: bib0006 article-title: Apoptosis and cancer: The genesis of a research field publication-title: Nat. Rev. Cancer contributor: fullname: Cotter – volume: 2 start-page: 60 year: 2012 ident: bib0025 article-title: The proline regulatory axis and cancer publication-title: Front. Oncol. contributor: fullname: Christian – volume: 89 start-page: 229 year: 2011 end-page: 236 ident: bib0027 article-title: Glutamine: Pleiotropic roles in tumor growth and stress resistance publication-title: J. Mol. Med. contributor: fullname: Abraham – volume: 19 start-page: 163 year: 2017 end-page: 194 ident: bib0034 article-title: Glutaminolysis: A hallmark of cancer metabolism publication-title: Ann. Rev. Biomed. Eng. contributor: fullname: Nagrath – volume: 104 start-page: 19345 year: 2007 end-page: 19350 ident: bib0007 article-title: Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis publication-title: Proceedings of the National Academy of Sciences of the United States of America contributor: fullname: Thompson – volume: 10 start-page: 369 year: 2000 end-page: 377 ident: bib0008 article-title: Mitochondria as the central control point of apoptosis publication-title: Trends Cell Biol. contributor: fullname: Martinou – volume: 13 start-page: 1111 year: 2005 end-page: 1118 ident: bib0012 article-title: Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site publication-title: Bioorg. Med. Chem. contributor: fullname: Rhoderick – volume: 16 start-page: 2 year: 2009 end-page: 16 ident: bib0030 article-title: Synergy research: Vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling publication-title: Phytomed. Int. J. Phytother. Phytopharmacol. contributor: fullname: Kraft – volume: 3 start-page: 1 year: 2015 ident: bib0001 article-title: Mitochondria as biosynthetic factories for cancer proliferation publication-title: Cancer Metab. contributor: fullname: Metallo – volume: 510 start-page: 298 year: 2014 end-page: 302 ident: bib0013 article-title: Quantitative flux analysis reveals folate-dependent NADPH production publication-title: Nature contributor: fullname: Rabinowitz – volume: 7 start-page: 32990 year: 2016 end-page: 33003 ident: bib0035 article-title: Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo publication-title: Oncotarget contributor: fullname: Sun – volume: 496 start-page: 101 year: 2013 end-page: 105 ident: bib0028 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature contributor: fullname: Kimmelman – volume: 23 start-page: 27 year: 2016 end-page: 47 ident: bib0024 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metab. contributor: fullname: Thompson – volume: 100 start-page: 86 year: 2016 end-page: 93 ident: bib0009 article-title: Mitochondrial ROS regulation of proliferating cells publication-title: Free Radical Biol. Med. contributor: fullname: Chandel – volume: 336 start-page: 1040 year: 2012 end-page: 1044 ident: bib0017 article-title: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation publication-title: Science contributor: fullname: Mootha – volume: 13 start-page: 572 year: 2013 end-page: 583 ident: bib0021 article-title: Serine, glycine and one-carbon units: Cancer metabolism in full circle publication-title: Nat. Rev. Cancer contributor: fullname: Locasale – volume: 22 start-page: 5793 year: 2002 end-page: 5800 ident: bib0023 article-title: A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism publication-title: Mol. Cell. Biol. contributor: fullname: Cole – volume: 818 start-page: 124 year: 2018 end-page: 131 ident: bib0010 article-title: DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo publication-title: Eur. J. Pharmacol. contributor: fullname: Sun – volume: 47 start-page: 349 year: 2012 end-page: 358 ident: bib0011 article-title: Glutaminolysis activates Rag-mTORC1 signaling publication-title: Mol. Cell contributor: fullname: Hall – volume: 63 start-page: 88 year: 2018 end-page: 98 ident: bib0015 article-title: Redox control in cancer development and progression publication-title: Mol. Aspects Med. contributor: fullname: Schroder – volume: 123 start-page: 3678 year: 2013 end-page: 3684 ident: bib0016 article-title: Glutamine and cancer: Cell biology, physiology, and clinical opportunities publication-title: J. Clin. Invest. contributor: fullname: DeBerardinis – volume: 29 start-page: 1379 year: 2013 end-page: 1386 ident: bib0036 article-title: The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity publication-title: Oncol. Rep. contributor: fullname: Zhang – volume: 174 start-page: 1131 year: 2017 end-page: 1146 ident: bib0005 article-title: Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer publication-title: Br. J. Pharmacol. contributor: fullname: Liang – volume: 273 start-page: 14484 year: 1998 end-page: 14494 ident: bib0014 article-title: Amino acid sufficiency and mTOR regulate p70S6 kinase and eIF-4E BP1 through a common effector mechanism publication-title: J. Biol. Chem. contributor: fullname: Avruch – volume: 22 start-page: 1007 year: 2015 end-page: 1017 ident: bib0018 article-title: Apoptosis in cancer: cause and cure publication-title: BioEssays contributor: fullname: Gores – volume: 8 start-page: 76458 year: 2017 end-page: 76467 ident: bib0022 article-title: Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo publication-title: Oncotarget contributor: fullname: Zou – volume: 10 start-page: 728 year: 2014 ident: bib0033 article-title: Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer publication-title: Mol. Syst. Biol. contributor: fullname: Nagrath – volume: 13 start-page: 184 year: 2011 end-page: 190 ident: bib0029 article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress publication-title: Nat. Cell Biol. contributor: fullname: Ron – volume: 274 start-page: 11647 year: 1999 end-page: 11652 ident: bib0019 article-title: Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6 publication-title: J. Biol. Chem. contributor: fullname: Jefferson – volume: 236 start-page: 278 year: 2015 end-page: 289 ident: bib0032 article-title: Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development publication-title: J. Pathol. contributor: fullname: Holst – volume: 83 start-page: 800 year: 2000 end-page: 810 ident: bib0026 article-title: Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells publication-title: Br. J. Cancer contributor: fullname: Wheatley – volume: 35 start-page: 3201 year: 2016 end-page: 3208 ident: bib0031 article-title: ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer publication-title: Oncogene contributor: fullname: Holst – volume: 104 start-page: 421 year: 2013 end-page: 431 ident: bib0003 article-title: Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis publication-title: Biophys. J. contributor: fullname: Garcia-Saez – volume: 16 start-page: 647 year: 2004 end-page: 652 ident: bib0004 article-title: Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases publication-title: Curr. Opin. Cell Biol. contributor: fullname: Xue – volume: 7 start-page: 1248 year: 2014 end-page: 1258 ident: bib0020 article-title: Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells publication-title: Cell Rep. contributor: fullname: Maddocks – volume: 123 start-page: 3678 year: 2013 ident: 10.1016/j.phymed.2018.12.011_bib0016 article-title: Glutamine and cancer: Cell biology, physiology, and clinical opportunities publication-title: J. Clin. Invest. doi: 10.1172/JCI69600 contributor: fullname: Hensley – volume: 273 start-page: 14484 year: 1998 ident: 10.1016/j.phymed.2018.12.011_bib0014 article-title: Amino acid sufficiency and mTOR regulate p70S6 kinase and eIF-4E BP1 through a common effector mechanism publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.23.14484 contributor: fullname: Hara – volume: 7 start-page: 1248 year: 2014 ident: 10.1016/j.phymed.2018.12.011_bib0020 article-title: Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.04.045 contributor: fullname: Labuschagne – volume: 10 start-page: 369 year: 2000 ident: 10.1016/j.phymed.2018.12.011_bib0008 article-title: Mitochondria as the central control point of apoptosis publication-title: Trends Cell Biol. doi: 10.1016/S0962-8924(00)01803-1 contributor: fullname: Desagher – volume: 104 start-page: 421 year: 2013 ident: 10.1016/j.phymed.2018.12.011_bib0003 article-title: Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis publication-title: Biophys. J. doi: 10.1016/j.bpj.2012.12.010 contributor: fullname: Bleicken – volume: 818 start-page: 124 year: 2018 ident: 10.1016/j.phymed.2018.12.011_bib0010 article-title: DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2017.10.014 contributor: fullname: Du – volume: 13 start-page: 1111 year: 2005 ident: 10.1016/j.phymed.2018.12.011_bib0012 article-title: Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2004.11.028 contributor: fullname: Esslinger – volume: 23 start-page: 27 year: 2016 ident: 10.1016/j.phymed.2018.12.011_bib0024 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.12.006 contributor: fullname: Pavlova – volume: 29 start-page: 1379 year: 2013 ident: 10.1016/j.phymed.2018.12.011_bib0036 article-title: The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity publication-title: Oncol. Rep. doi: 10.3892/or.2013.2272 contributor: fullname: Zhao – volume: 3 start-page: 1 year: 2015 ident: 10.1016/j.phymed.2018.12.011_bib0001 article-title: Mitochondria as biosynthetic factories for cancer proliferation publication-title: Cancer Metab. doi: 10.1186/s40170-015-0128-2 contributor: fullname: Ahn – volume: 16 start-page: 647 year: 2004 ident: 10.1016/j.phymed.2018.12.011_bib0004 article-title: Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases publication-title: Curr. Opin. Cell Biol. doi: 10.1016/j.ceb.2004.09.009 contributor: fullname: Breckenridge – volume: 19 start-page: 163 year: 2017 ident: 10.1016/j.phymed.2018.12.011_bib0034 article-title: Glutaminolysis: A hallmark of cancer metabolism publication-title: Ann. Rev. Biomed. Eng. doi: 10.1146/annurev-bioeng-071516-044546 contributor: fullname: Yang – volume: 336 start-page: 1040 year: 2012 ident: 10.1016/j.phymed.2018.12.011_bib0017 article-title: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation publication-title: Science doi: 10.1126/science.1218595 contributor: fullname: Jain – volume: 22 start-page: 5793 year: 2002 ident: 10.1016/j.phymed.2018.12.011_bib0023 article-title: A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.22.16.5793-5800.2002 contributor: fullname: Nikiforov – volume: 13 start-page: 184 year: 2011 ident: 10.1016/j.phymed.2018.12.011_bib0029 article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress publication-title: Nat. Cell Biol. doi: 10.1038/ncb0311-184 contributor: fullname: Tabas – volume: 174 start-page: 1131 year: 2017 ident: 10.1016/j.phymed.2018.12.011_bib0005 article-title: Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer publication-title: Br. J. Pharmacol. doi: 10.1111/bph.13765 contributor: fullname: Chen – volume: 47 start-page: 349 year: 2012 ident: 10.1016/j.phymed.2018.12.011_bib0011 article-title: Glutaminolysis activates Rag-mTORC1 signaling publication-title: Mol. Cell doi: 10.1016/j.molcel.2012.05.043 contributor: fullname: Duran – volume: 496 start-page: 101 year: 2013 ident: 10.1016/j.phymed.2018.12.011_bib0028 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature doi: 10.1038/nature12040 contributor: fullname: Son – volume: 7 start-page: 32990 year: 2016 ident: 10.1016/j.phymed.2018.12.011_bib0035 article-title: Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo publication-title: Oncotarget doi: 10.18632/oncotarget.8843 contributor: fullname: Yu – volume: 13 start-page: 572 year: 2013 ident: 10.1016/j.phymed.2018.12.011_bib0021 article-title: Serine, glycine and one-carbon units: Cancer metabolism in full circle publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3557 contributor: fullname: Locasale – volume: 35 start-page: 3201 year: 2016 ident: 10.1016/j.phymed.2018.12.011_bib0031 article-title: ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer publication-title: Oncogene doi: 10.1038/onc.2015.381 contributor: fullname: van Geldermalsen – volume: 510 start-page: 298 year: 2014 ident: 10.1016/j.phymed.2018.12.011_bib0013 article-title: Quantitative flux analysis reveals folate-dependent NADPH production publication-title: Nature doi: 10.1038/nature13236 contributor: fullname: Fan – volume: 7 start-page: 7425 year: 2017 ident: 10.1016/j.phymed.2018.12.011_bib0002 article-title: Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming publication-title: Sci. Rep. doi: 10.1038/s41598-017-07631-9 contributor: fullname: Bernstock – volume: 2 start-page: 60 year: 2012 ident: 10.1016/j.phymed.2018.12.011_bib0025 article-title: The proline regulatory axis and cancer publication-title: Front. Oncol. doi: 10.3389/fonc.2012.00060 contributor: fullname: Phang – volume: 274 start-page: 11647 year: 1999 ident: 10.1016/j.phymed.2018.12.011_bib0019 article-title: Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.17.11647 contributor: fullname: Kimball – volume: 16 start-page: 2 year: 2009 ident: 10.1016/j.phymed.2018.12.011_bib0030 article-title: Synergy research: Vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling publication-title: Phytomed. Int. J. Phytother. Phytopharmacol. contributor: fullname: Ulrich-Merzenich – volume: 236 start-page: 278 year: 2015 ident: 10.1016/j.phymed.2018.12.011_bib0032 article-title: Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development publication-title: J. Pathol. doi: 10.1002/path.4518 contributor: fullname: Wang – volume: 100 start-page: 86 year: 2016 ident: 10.1016/j.phymed.2018.12.011_bib0009 article-title: Mitochondrial ROS regulation of proliferating cells publication-title: Free Radical Biol. Med. doi: 10.1016/j.freeradbiomed.2016.04.198 contributor: fullname: Diebold – volume: 8 start-page: 76458 year: 2017 ident: 10.1016/j.phymed.2018.12.011_bib0022 article-title: Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo publication-title: Oncotarget doi: 10.18632/oncotarget.19479 contributor: fullname: Lu – volume: 10 start-page: 728 year: 2014 ident: 10.1016/j.phymed.2018.12.011_bib0033 article-title: Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer publication-title: Mol. Syst. Biol. doi: 10.1002/msb.20134892 contributor: fullname: Yang – volume: 9 start-page: 501 year: 2009 ident: 10.1016/j.phymed.2018.12.011_bib0006 article-title: Apoptosis and cancer: The genesis of a research field publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2663 contributor: fullname: Cotter – volume: 89 start-page: 229 year: 2011 ident: 10.1016/j.phymed.2018.12.011_bib0027 article-title: Glutamine: Pleiotropic roles in tumor growth and stress resistance publication-title: J. Mol. Med. doi: 10.1007/s00109-011-0731-9 contributor: fullname: Shanware – volume: 22 start-page: 1007 year: 2015 ident: 10.1016/j.phymed.2018.12.011_bib0018 article-title: Apoptosis in cancer: cause and cure publication-title: BioEssays doi: 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4 contributor: fullname: Kaufmann – volume: 63 start-page: 88 year: 2018 ident: 10.1016/j.phymed.2018.12.011_bib0015 article-title: Redox control in cancer development and progression publication-title: Mol. Aspects Med. doi: 10.1016/j.mam.2018.02.003 contributor: fullname: Helfinger – volume: 83 start-page: 800 year: 2000 ident: 10.1016/j.phymed.2018.12.011_bib0026 article-title: Single amino acid (arginine) deprivation: Rapid and selective death of cultured transformed and malignant cells publication-title: Br. J. Cancer doi: 10.1054/bjoc.2000.1353 contributor: fullname: Scott – volume: 104 start-page: 19345 year: 2007 ident: 10.1016/j.phymed.2018.12.011_bib0007 article-title: Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis contributor: fullname: DeBerardinis |
SSID | ssj0014970 |
Score | 2.4254167 |
Snippet | Topotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to increase... BACKGROUNDTopotecan (TPT) is a Topo I inhibitor and shows obvious anti-cancer effects on gastric cancer. Cancer cells reprogram their metabolic pathways to... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 117 |
SubjectTerms | Apoptosis ASCT2 Gastric cancer Oxidative stress Topotecan |
Title | Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer |
URI | https://dx.doi.org/10.1016/j.phymed.2018.12.011 https://www.ncbi.nlm.nih.gov/pubmed/30668314 https://search.proquest.com/docview/2179423389 |
Volume | 57 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7BIlVcqkJ5bEuRkRAnzCaON2sfV6uibVcgCovKzfLaCUoPSUSWqlz625nJA8QBIZFLlChWHM9kvm_smTHA4dB7tcCDS6djjngtuZaB5CrViBhOOyEpOfnsPJ5ey583w5sVmHS5MBRW2dr-xqbX1rq9M2hHc1Bm2eAKHRO0rCEpZYA0XK3CGsKRlD1YG_-YTc-fFhOkrveMo-c5Negy6OowL_wYhB2K8VL1vGAYvoZQrzHQGolOP8HHlkKycdPLDVhJ8k34cNYukm_C0UVTjvrhmM2fs6uqY3bELp4LVT98hl_zoqQqDTZn6JmjjCtmy6JcFlVWsb-ZZeOryVywOrkEiSkr_mW-rhPOmgwTbMVuLW384Zgj7bnbguvT7_PJlLdbLHCHyLXk3iWIktHQK6tFir6ST6PYS--CVJDrKFxiUxtElupyBaNYq1AKr52NVIrc0Ubb0MuLPNkF5tOUuMZoIaKhtNIthLZUOx59Hq-QdfaBd8NqyqaShulCzP6YRgyGxGBCYVAMfRh1Y29eaIRBY_9Gy4NOVAZ_FloBsXlS3FdGkPkR6JXrPuw0MnzqCypRrKJQfnn3e7_COl7pJq5nD3rLu_vkG1KW5WIfVk_-h_utYtJ5dvl79ghq4evH |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED51Rdr2gli3sQ7YPAnxhNXEcVL7sapAZaUVE0HizXLtBIWHJCIFwX-_c36AeKiQyGMSK87d5e67-O4zwGForVjhQbmREcV4zankHqcilRgxjDSMu-bkxTKaXfG_1-F1D6ZdL4wrq2x9f-PTa2_dnhm10hyVWTa6xMQEPavvjNJDGC4-wBYPxz7vw9bkbD5bPi8mcFnvGefup25A10FXl3nhy2DYcTVeov4v6PubItQmBFpHotMd2G4hJJk0s_wCvSQfwMdFu0g-gKOLho766ZjEL91V1TE5IhcvRNVPX-FfXJSOpUHnBDNz1HFFdFmU66LKKvKQaTK5nMaM1M0lCExJ8ZjZmiecNB0mOIrcaLfxhyHGWc_dN7g6PYmnM9pusUANRq41tSbBKBmEVmjJUsyVbBpEllvjpcyljswkOtVeoB0vlzeOpPA5s9LoQKSIHXXwHfp5kSc_gNg0dVhjvGJByDU3Kya1447HnMcKRJ1DoJ1YVdkwaaiuxOxWNWpQTg3KZwrVMIRxJ3v1yiIUOvs3Rv7pVKXwY3ErIDpPivtKMed-GGblcgi7jQ6f54JGFInA5z_f_dzf8GkWL87V-dlyvgef8Ypsanz2ob--u08OEL6sV79a8_wPudjsFg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Topotecan+induces+apoptosis+via+ASCT2+mediated+oxidative+stress+in+gastric+cancer&rft.jtitle=Phytomedicine+%28Stuttgart%29&rft.au=Wang%2C+Lai&rft.au=Liu%2C+Yang&rft.au=Zhao%2C+Ting-Li&rft.au=Li%2C+Zheng-Zheng&rft.date=2019-04-01&rft.pub=Elsevier+GmbH&rft.issn=0944-7113&rft.eissn=1618-095X&rft.volume=57&rft.spage=117&rft.epage=128&rft_id=info:doi/10.1016%2Fj.phymed.2018.12.011&rft.externalDocID=S0944711318306068 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-7113&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-7113&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-7113&client=summon |